David Drasin, PhD, currently serves as Executive Director of R&D Strategy and Operations at Amgen, where responsibilities include leading global competitive intelligence for the solid tumor pipeline and shaping commercial strategies. Drasin’s previous roles include Principal at the UCLA Technology Development Group, overseeing investments in early therapeutic discoveries, and Life Science Consultant at BluePrint Research Group, focusing on commercial strategy across various therapeutic areas. With a strong academic background that includes a PhD in Molecular Biology from the University of Colorado Anschutz Medical Campus, Drasin has also engaged in research on breast cancer progression and supported innovation at UCSF. Additionally, early career experiences include roles in cytogenetics and laboratory technology.
This person is not in any teams
This person is not in any offices